Please assess the completion status of the following clinical trial:

Trial Title: High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* osteosarcoma~* eligible to receive 2 sequential cycles of HDMTX-LV~Exclusion Criteria:~* prior administration of glucarpidase~* progression of disease while on previous MTX treatment

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): HDMTX-LV with glucarpidase
- B (Type: ACTIVE_COMPARATOR): HDMTX-LV with placebo
- C (Type: EXPERIMENTAL): compassionate use group to treat or prevent life threatening toxicity in the event of delayed elimination of MTX and/or renal impairment

Based on this trial design, predict the completion outcome and termination type (if applicable).